MiniMed Group Inc (NASDAQ:MMED – Get Free Report) was the recipient of a large increase in short interest during the month of September. As of September 15th, there was short interest totaling 13,594,922 shares, an increase of 68.7% from the August 31st total of 8,060,409 shares. Based on an average daily volume of 2,805,245 shares, the days-to-cover ratio is presently 4.8 days. Approximately 4.8% of the shares of the stock are short sold.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on the stock. Citigroup boosted their target price on shares of MiniMed Group from $23.00 to $26.00 and gave the stock a “buy” rating in a research report on Wednesday, September 2nd. Benchmark reissued a “buy” rating on shares of MiniMed Group in a research note on Thursday, June 4th. Truist Financial assumed coverage on shares of MiniMed Group in a report on Thursday, September 24th. They issued a “buy” rating and a $29.00 target price for the company. Weiss Ratings upgraded shares of MiniMed Group from a “sell (d-)” rating to a “sell (d)” rating in a report on Wednesday, September 9th. Finally, Wells Fargo & Company upped their price objective on shares of MiniMed Group from $22.00 to $26.00 and gave the company an “overweight” rating in a research note on Wednesday, September 2nd. Fourteen research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $24.14.
View Our Latest Research Report on MiniMed Group
Hedge Funds Weigh In On MiniMed Group
MiniMed Group Stock Up 0.7%
MiniMed Group stock traded up $0.13 during midday trading on Thursday, reaching $19.60. The stock had a trading volume of 3,933,135 shares, compared to its average volume of 1,356,074. The firm’s 50-day moving average price is $20.34 and its 200 day moving average price is $16.27. The firm has a market capitalization of $5.51 billion and a PE ratio of -28.82. MiniMed Group has a 12 month low of $10.65 and a 12 month high of $24.43.
About MiniMed Group
We are a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes. Today, we are the only player in the market that commercializes all parts of an integrated diabetes management system.
Featured Articles
- Five stocks we like better than MiniMed Group
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Appleās $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for MiniMed Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiniMed Group and related companies with MarketBeat.com's FREE daily email newsletter.
